Description

tert-Butyl 2-Formyl-6,7-Dihydrothiazolo[5,4-C]Pyridine-5(4H)-Carboxylate is a high-value, advanced pharmaceutical intermediate characterized by its fused heterocyclic structure containing thiazole and pyridine rings. This compound serves as a critical building block in modern medicinal chemistry, enabling the synthesis of complex molecules with targeted biological activity. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of novel therapeutic agents, particularly within oncology and central nervous system (CNS) drug discovery pipelines.

Application

• Pharmaceutical Intermediate: A key synthetic precursor for the development of small-molecule drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to create novel bioactive compounds.
• API Synthesis: Serves as a core scaffold in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs), especially those with fused heterocyclic architectures.
• Chemical Biology Probes: Employed in the design and synthesis of molecular probes for studying enzyme function and cellular signaling mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Product Name	tert-Butyl 2-Formyl-6,7-Dihydrothiazolo[5,4-C]Pyridine-5(4H)-Carboxylate
CAS No.	365996-10-7
Molecular Formula	C13H16N2O3S
Molecular Weight	280.34 g/mol
Synonyms	5-tert-Butoxycarbonyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxaldehyde; 2-Formyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-5-carboxylic acid tert-butyl ester; tert-Butyl 2-formyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-5-carboxylate; BOC-protected thiazolopyridine aldehyde; 365996-10-7; Thiazolo[5,4-c]pyridine-2-carboxaldehyde, 4,5,6,7-tetrahydro-5-[(1,1-dimethylethoxy)carbonyl]-
EINECS	Contact for details

Quality Control

Our tert-Butyl 2-Formyl-6,7-Dihydrothiazolo[5,4-C]Pyridine-5(4H)-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure high purity and structural identity consistent with pharmaceutical intermediate standards. Certificates of Analysis (COA) detailing purity, impurities, and other critical parameters are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat and incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Individual impurity ≤ 1.0%
Total Impurities	≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.